PURE Bioscience (OTCMKTS:PURE – Get Free Report)’s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.07 and traded as high as $0.09. PURE Bioscience shares last traded at $0.08, with a volume of 136,475 shares traded.
PURE Bioscience Stock Performance
The business has a 50-day simple moving average of $0.08 and a two-hundred day simple moving average of $0.07. The company has a market capitalization of $8.39 million, a price-to-earnings ratio of -1.88 and a beta of 0.31.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last announced its earnings results on Monday, June 16th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.49 million during the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Articles
- Five stocks we like better than PURE Bioscience
- What is a Stock Market Index and How Do You Use Them?
- Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside
- What Are Dividend Champions? How to Invest in the Champions
- Breakout Alert: Disney Stock Hits Multi-Year High
- How to Use Stock Screeners to Find Stocks
- Forget IBM: Accenture’s AI Momentum Is Your Next Buy
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
